Welcome to
(Demark)
(France)
(Austria)(Germany)(Switzerland)
(Italy)
(Brazil)(Portugal)
(Argentina)(Dominican Republic)(Guatemala)
(Mexico)(Peru)(Spain)
The Romberg's Connection
For more information and to join our Romberg's Connection, please e-mail us at rombergs@hotmail.com.
On May 23, 2013 we joined the Invitae Patient Insights Network which “is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. We believe that patients own their data and have the right to share it in a manner that protects their privacy.”
To learn more click here.
To register with the Invitae Patient Insights Network, please go to Parry Romberg.Connect Patient Registry .
Summary
Localized scleroderma designates a heterogeneous group of sclerotic skin disorders. Depending on the subtype, severity, and site affected, adjacent structures such as adipose tissue, muscles, joints, and bones may be involved. This is an update of the existing German AWMF (Association of the Scientific Medical Societies in Germany) guidelines (classification: S2k). These guidelines provide an overview of the definition, epidemiology, classification, pathogenesis, laboratory workup, histopathology, clinical scoring systems, as well as imaging and device-based workup of localized scleroderma. Moreover, consensus-based recommendations are given on the management of localized scleroderma depending on its clinical subtype. Treatment recommendations are presented in a therapeutic algorithm. No financial support was given by any pharmaceutical company. The guidelines are valid until July 2019.
Guestbook Archives
Past Visitors
For more information and to join our Romberg's Connection, please e-mail us at rombergs@hotmail.com.
For questions or comments about this website, please contact Gerri Neal.